249
IRUS TotalDownloads
Altmetric
Dietary supplementation with inulin-propionate ester or inulin improves insulin sensitivity in adults with overweight and obesity with distinct effects on the gut microbiota, plasma metabolome and systemic inflammatory responses: a randomised cross-over trial
File | Description | Size | Format | |
---|---|---|---|---|
DietarySupplementationWithInulinPropionateEster.pdf | Published version | 2.51 MB | Adobe PDF | View/Open |
Title: | Dietary supplementation with inulin-propionate ester or inulin improves insulin sensitivity in adults with overweight and obesity with distinct effects on the gut microbiota, plasma metabolome and systemic inflammatory responses: a randomised cross-over trial |
Authors: | Chambers, E Byrne, C Morrison, D Murphy, K Preston, T Tedford, MC Garcia Perez, I Fountana, S Serrano Contreras, J Holmes, E Roberts, J Reynolds, C Boyton, R Altmann, D McDonald, J Marchesi, J Akbar, A Riddell, N Wallis, G Frost, G |
Item Type: | Journal Article |
Abstract: | Objective: To investigate the underlying mechanisms behind changes in glucose homeostasis with delivery of propionate to the human colon by comprehensive and coordinated analysis of gut bacterial composition, plasma metabolome and immune responses. Design: Twelve non-diabetic adults with overweight and obesity received 20g/day of inulin-propionate ester (IPE), designed to selectively deliver propionate to the colon, a high-fermentable fibre control (inulin) and a low-fermentable fibre control (cellulose) in a randomised, double-blind, placebo controlled, crossover design. Outcome measurements of metabolic responses, inflammatory markers and gut bacterial composition were analysed at the end of each 42-day supplementation period. Results: Both IPE and inulin supplementation improved insulin resistance compared to cellulose supplementation, measured by homeostatic model assessment (HOMA) 2 (Mean±SEM 1.23±0.17 IPE vs. 1.59±0.17 cellulose, P=0.001; 1.17±0.15 inulin vs. 1.59±0.17 cellulose, P=0.009), with no differences between IPE and inulin (P=0.272). Fasting insulin was only associated positively with plasma tyrosine and negatively with plasma glycine following inulin supplementation. IPE supplementation decreased pro-inflammatory IL-8 levels compared to cellulose, whilst inulin had no impact on the systemic inflammatory markers studied. Inulin promoted changes in gut bacterial populations at the class level (increased Actinobacteria and decreased Clostridia) and order level (decreased Clostridales) compared to cellulose, with small differences at the species level observed between IPE and cellulose. Conclusion: These data demonstrate a distinctive physiological impact of raising colonic propionate delivery in humans, as improvements in insulin sensitivity promoted by IPE and inulin were accompanied with different effects on the plasma metabolome, gut bacterial populations and markers of systemic inflammation. |
Issue Date: | 5-Jul-2019 |
Date of Acceptance: | 24-Feb-2019 |
URI: | http://hdl.handle.net/10044/1/66974 |
DOI: | https://doi.org/10.1136/gutjnl-2019-318424 |
ISSN: | 0017-5749 |
Publisher: | BMJ Publishing Group |
Start Page: | 1430 |
End Page: | 1438 |
Journal / Book Title: | Gut |
Volume: | 68 |
Issue: | 8 |
Copyright Statement: | © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
Sponsor/Funder: | Biotechnology and Biological Sciences Research Council (BBSRC) Welton Foundation Imperial College Healthcare NHS Trust- BRC Funding Versus Arthritis Biotechnology and Biological Sciences Research Council (BBSRC) Imperial Health Charity Imperial College Healthcare NHS Trust- BRC Funding |
Funder's Grant Number: | BB/L004259/1 N/A RDF01 79560 21135 BB/H004971/1 80108 RDA27 |
Keywords: | Science & Technology Life Sciences & Biomedicine Gastroenterology & Hepatology CHAIN FATTY-ACIDS TARGETED DELIVERY BODY-WEIGHT PROTEIN GLUCOSE FIBER RISK BIFIDOBACTERIA RESISTANCE DISEASE colonic microflora glucose metabolism inflammation short-chain fatty acids Adult Body Mass Index Cross-Over Studies Dietary Supplements Double-Blind Method Feces Female Gastrointestinal Microbiome Humans Inflammation Insulin Insulin Resistance Inulin Male Metabolome Middle Aged Obesity Overweight Propionates Treatment Outcome Feces Humans Insulin Resistance Obesity Inflammation Propionates Inulin Insulin Body Mass Index Treatment Outcome Cross-Over Studies Double-Blind Method Dietary Supplements Adult Middle Aged Female Male Overweight Metabolome Gastrointestinal Microbiome 1103 Clinical Sciences 1114 Paediatrics and Reproductive Medicine Gastroenterology & Hepatology |
Publication Status: | Published online |
Online Publication Date: | 2019-04-10 |
Appears in Collections: | Department of Infectious Diseases |